(1)
Moore, K. T.; Langas, M. Use of Rivaroxaban and Apixaban, Two Non-Vitamin K Antagonist Oral Anticoagulants (NOACs), in Renally Impaired Patients - the Limits of Our Knowledge. J Cardiol Cardiovasc Med 2018, 3, 049-051.